Company record
Extract Labs produces private‑label cannabinoid formulations for commercial markets. Its portfolio includes CBD, CBN, CBG, CBDA, CBGA, CBC and delta‑9 THC, which are offered as oils, tinctures, gummies, capsules, topicals, vaporizable liquids and pods. The product line is targeted toward applications such as stress relief, sleep support, mood enhancement, pain management and pet care.
This directory record does not yet have a linked material-flow brief.